Clinical Trial Update: Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

View source ↗

Summary

Clinical trial update describing long-term safety outcomes and initial first-line treatment patterns in patients with non-small cell lung cancer and low PD-L1 e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-small Cell Lung Cancer (NSCLC) | Status: ACTIVE_NOT_RECRUITING